HCA Healthcare, Inc.
As of Oct 23, 2026 close
- Market cap
- $104.51B
- P/E (TTM)
- 15.28
- Forward P/E
- 13.66
- Dividend yield
- 0.65%
- 52-week range
- $353.99$556.52
- Volume (live)
- -
- Avg. volume (3M)
- 1.26M
HCA Healthcare (HCA) Stock Price & Financial Analysis
HCA Healthcare Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $461.77 - $473.46 |
|---|---|
| 52-Week High | $556.52 |
| 52-Week Low | $353.99 |
| Open | $465.76 |
| Volume (last close) | 1.03M |
| Average Volume (3M) | 1.26M |
| Revenue (TTM) | 78.01B |
|---|---|
| Net Income (TTM) | 6.84B |
| Free Cash Flow (TTM) | 6.00B |
| EPS (TTM) | $29.86 |
| Profit Margin | 8.77% |
| Operating Margin | 15.48% |
| Annual Dividend | $3.06 |
|---|---|
| Dividend Yield | 0.65% |
| Payout Ratio | 10.25% |
| Last Dividend Ex-Date | Sep 16, 2026 |
| Market Cap | 104.51B |
|---|---|
| Shares Outstanding | 222.83M |
| P/E Ratio (TTM) | 15.28 |
| Forward P/E | 13.66 |
| Price to Sales (P/S) | 1.34 |
| Price to Book (P/B) | -15.74 |
| EV/EBITDA | 9.64 |
| 50-Day MA | $428.35 |
|---|---|
| 200-Day MA | $444.84 |
| 1-Year Change | +6.17% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
HCA Healthcare at a Glance
As of the Oct 23, 2026 close, HCA Healthcare (HCA) has a market capitalization of $104.51B. The stock trades at 15.3× trailing earnings, 13.7× forward earnings and 1.3× sales. Over the trailing twelve months it earned $6.84B on revenue of $78.01B (a 8.8% profit margin) and generated $6.00B of free cash flow. Revenue grew 7.3% year over year.
As of its latest reported balance sheet, it holds $1.01B in cash and securities against $49.72B of debt, a net debt position of $48.70B.
HCA Healthcare pays a quarterly dividend totaling $3.06 per share a year, a 0.65% yield at the Oct 23, 2026 close, with a 10% payout ratio and 5 consecutive years of dividend increases.
The share price is up 6.2% over the past year. At $469.03 (the Oct 23, 2026 close) it sits within its 52-week range of $353.99 to $556.52, above its 200-day moving average of $444.84.
Based on 15 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $449.09, 4.3% below the Oct 23, 2026 close.
Frequently Asked Questions About HCA Healthcare
What is the current stock price for HCA?
As of the Oct 23, 2026 close, HCA stock trades at $469.03. The 52-week range is $353.99–$556.52, with a day range of $461.77–$473.46.
What is the P/E ratio for HCA?
As of the Oct 23, 2026 close, HCA Healthcare's trailing twelve-month (TTM) P/E ratio is 15.3, meaning investors pay $15.3 for every $1 of annual earnings. The forward P/E is 13.7, reflecting analyst expectations for future earnings. HCA Healthcare operates in the Healthcare sector.
Does HCA pay dividends?
Yes, HCA Healthcare pays a 0.65% annual dividend yield as of the Oct 23, 2026 close ($3.06 per share a year). The trailing twelve-month payout ratio is 10.3%. The most recent ex-dividend date was September 16, 2026.
What do analysts recommend for HCA?
Based on ratings from 15 professional analysts over the last 90 days, the consensus for HCA is Buy. The average 12-month price target is $449.09, a 4.3% downside from the Oct 23, 2026 close of $469.03.
What is the market cap of HCA?
As of the Oct 23, 2026 close, HCA Healthcare's market capitalization is $104.51B, classifying it as a large-cap company. HCA Healthcare operates in the Healthcare sector within the Medical Care Facilities industry.